159 related articles for article (PubMed ID: 32087259)
1. Pluronic micelles with suppressing doxorubicin efflux and detoxification for efficiently reversing breast cancer resistance.
Cheng X; Lv X; Xu J; Zheng Y; Wang X; Tang R
Eur J Pharm Sci; 2020 Apr; 146():105275. PubMed ID: 32087259
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity.
Wei Z; Yuan S; Hao J; Fang X
Eur J Pharm Biopharm; 2013 Feb; 83(2):266-74. PubMed ID: 23089310
[TBL] [Abstract][Full Text] [Related]
3. Reversing multidrug resistance by intracellular delivery of Pluronic® P85 unimers.
Hong W; Chen D; Zhang X; Zeng J; Hu H; Zhao X; Qiao M
Biomaterials; 2013 Dec; 34(37):9602-14. PubMed ID: 24021757
[TBL] [Abstract][Full Text] [Related]
4. Multifunctionalized Micelles Facilitate Intracellular Doxorubicin Delivery for Reversing Multidrug Resistance of Breast Cancer.
Cao A; Ma P; Yang T; Lan Y; Yu S; Liu L; Sun Y; Liu Y
Mol Pharm; 2019 Jun; 16(6):2502-2510. PubMed ID: 30998372
[TBL] [Abstract][Full Text] [Related]
5. Active-targeting and acid-sensitive pluronic prodrug micelles for efficiently overcoming MDR in breast cancer.
Xu C; Xu J; Zheng Y; Fang Q; Lv X; Wang X; Tang R
J Mater Chem B; 2020 Apr; 8(13):2726-2737. PubMed ID: 32154530
[TBL] [Abstract][Full Text] [Related]
6. pH-sensitive pluronic micelles combined with oxidative stress amplification for enhancing multidrug resistance breast cancer therapy.
Cheng X; Zeng X; Zheng Y; Fang Q; Wang X; Wang J; Tang R
J Colloid Interface Sci; 2020 Apr; 565():254-269. PubMed ID: 31978788
[TBL] [Abstract][Full Text] [Related]
7. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor.
Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X
Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286
[TBL] [Abstract][Full Text] [Related]
8. Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer.
Mao J; Qiu L; Ge L; Zhou J; Ji Q; Yang Y; Long M; Wang D; Teng L; Chen J
Biomed Pharmacother; 2021 Feb; 134():111108. PubMed ID: 33341670
[TBL] [Abstract][Full Text] [Related]
9. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
[TBL] [Abstract][Full Text] [Related]
10. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
[TBL] [Abstract][Full Text] [Related]
11. Redox-responsive F127-folate/F127-disulfide bond-d-α-tocopheryl polyethylene glycol 1000 succinate/P123 mixed micelles loaded with paclitaxel for the reversal of multidrug resistance in tumors.
Lin J; Zhao C; Liu C; Fu S; Han L; Lu X; Yang C
Int J Nanomedicine; 2018; 13():805-830. PubMed ID: 29445276
[TBL] [Abstract][Full Text] [Related]
12. Pluronic P123 modified nano micelles loaded with doxorubicin enhanced tumor-suppressing effect on drug-resistant breast cancer cells.
Zhang X; Chen W; Bai J; Jin L; Kang X; Zhang H; Wang Z
Aging (Albany NY); 2020 May; 12(9):8289-8300. PubMed ID: 32396524
[TBL] [Abstract][Full Text] [Related]
13. Mixed Micelles for Targeted and Efficient Doxorubicin Delivery to Multidrug-Resistant Breast Cancer Cells.
Jung H; Mok H
Macromol Biosci; 2016 May; 16(5):748-58. PubMed ID: 26806493
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization.
Wei Z; Hao J; Yuan S; Li Y; Juan W; Sha X; Fang X
Int J Pharm; 2009 Jul; 376(1-2):176-85. PubMed ID: 19409463
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin loaded singlet-oxygen producible polymeric micelle based on chlorine e6 conjugated pluronic F127 for overcoming drug resistance in cancer.
Park H; Park W; Na K
Biomaterials; 2014 Sep; 35(27):7963-9. PubMed ID: 24934645
[TBL] [Abstract][Full Text] [Related]
16. Pluronic mixed micelles overcoming methotrexate multidrug resistance: in vitro and in vivo evaluation.
Chen Y; Sha X; Zhang W; Zhong W; Fan Z; Ren Q; Chen L; Fang X
Int J Nanomedicine; 2013; 8():1463-76. PubMed ID: 23620663
[TBL] [Abstract][Full Text] [Related]
17. Thermo-triggerable self-assembly comprising cinnamoyl polymeric β cyclodextrin and cinnamoyl Pluronic F127.
Wang MH; Jeong JH; Kim JC
Colloids Surf B Biointerfaces; 2016 Jun; 142():148-158. PubMed ID: 26952358
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin derivative loaded acetal-PEG-PCCL micelles for overcoming multidrug resistance in MCF-7/ADR cells.
Zhong XC; Xu WH; Wang ZT; Guo WW; Chen JJ; Guo NN; Wang TT; Lin MT; Zhang ZT; Lu YY; Yang QY; Han M; Xu DH; Gao JQ
Drug Dev Ind Pharm; 2019 Sep; 45(9):1556-1564. PubMed ID: 31271317
[No Abstract] [Full Text] [Related]
19. Targeted delivery of anticancer drugs by aptamer AS1411 mediated Pluronic F127/cyclodextrin-linked polymer composite micelles.
Li X; Yu Y; Ji Q; Qiu L
Nanomedicine; 2015 Jan; 11(1):175-84. PubMed ID: 25218928
[TBL] [Abstract][Full Text] [Related]
20. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W
J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
